Report : North America Vision Care Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by (Eyeglasses, Contact Lens, Intraocular Lens, and Others) and Distribution Channel (Retail Stores, E-Commerce, Clinics, and Hospitals)

At 5.1% CAGR, the North America Vision Care Market is speculated to be worth US$ 39,979.00 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the North America vision care market was valued at US$ 29,645.11 million in 2022 and is expected to reach US$ 39,979.00 million by 2028, registering a CAGR of 5.1% from 2022 to 2028. Growing prevalence of eye diseases and development of innovative products are the critical factors attributed to the North America vision care market expansion.

A wide variety of eye diseases, including cataracts, glaucoma, and refractive errors, are prevalent across the North America. According to data provided by the Centers for Disease Control and Prevention (CDC), ~12 million people in the US, aged 40 and above, suffered from vision impairment in 2022, out of which 3 million had vision impairment after correction and 8 million suffered from vision impairment due to uncorrected refractive index. Increasing incidences of diabetes and other chronic diseases are responsible for such a high prevalence of vision impairment in the US population. According to the results of the Canadian Health Measures Survey conducted over 2016–2019, 50.4% of adults aged 40–64 and 71.6% of seniors aged 65–79 indicated they had visited an eye care professional in the past year.

Further, the increasing age of populations and workforces in the region, and the increased visual demands of modern occupations underline the impact of low vision and blindness on economies. Thus, a high prevalence of vision impairment and blindness in the region boosts the growth of the vision care market. This is expected to drive the North America vision care market during the forecast period.

On the contrary, adverse effects of contact lens on eye health hurdles the growth of North America vision care market. 

Based on type, the North America vision care market is categorized into eyeglasses, contact lens, intraocular lens, and others. The eyeglasses segment held 52.9% market share in 2022, amassing US$ 15,672.14 million. It is projected to garner US$ 21,793.02 million by 2028 to expand at 5.6% CAGR during 2022–2028.

Based on distribution channel, the North America vision care market is categorized into retail stores, e-commerce, clinics, and hospitals. The retail stores segment held 45.5% market share in 2022, amassing US$ 13,497.45 million. It is projected to garner US$ 18,459.36 million by 2028 to expand at 5.4% CAGR during 2022–2028.

Based on country, the North America vision care market has been categorized into the US, Canada, and Mexico.  Our regional analysis states that the US captured 80.2% share of North America vision care market in 2022. It was assessed at US$ 23,762.25 million in 2022 and is likely to hit US$ 32,412.12 million by 2028, exhibiting a CAGR of 5.3% during the forecast period. 

Key players dominating the North America vision care market are Alcon Inc.; Bausch Health Companies Inc.; Carl Zeiss AG; Cooper Companies Inc; Essilor International SAS; Johnson & Johnson; Hoya Corp; Rodenstock GMBH; Menicon Co., Ltd; and Rayner Intraocular Lenses Limited among others.

  • In Mar 2022, Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S.
  • In Oct 2020, BAUSCH + LOMB launched Simplifeye IOL delivery system for envista toric, and monofocal preloaded intraocular lenses.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com

Download Free PDF Brochure